ArticleTransfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie2026
ABO Incongruency Increases Risk for Necrotizing Enterocolitis in Preterm Neonates.
Article in Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Preterm neonates are at high risk for complications, and inflammation has been implicated in many of these pathologies. ABO incongruency occurs when the maternal and neonatal blood types are different and may cause complications when the mother creates antibodies against neonatal blood type antigens. In this study, we investigated whether preterm neonates with type A or B blood born to mothers with type O blood (ABO incongruent) had higher rates of neonatal complications than neonates with type O blood born to mothers with type O blood (ABO congruent). We hypothesized that preterm neonates who were ABO incongruent would have a higher incidence of neonatal morbidity. Methods: This was a population-based single-center retrospective cohort study of 371 preterm neonates whose mothers had O blood type, were born between 21 0/7 and 32 6/7 weeks gestation, and admitted to University of Iowa Health Care Neonatal Intensive Care Unit between January 2018 and December 2022. Neonates were grouped by ABO incongruent versus congruent as well as by gestational age (GA) (22-26 and 27-32 weeks GA). Demographics data were collected. Outcomes included bronchopulmonary dysplasia, pulmonary hypertension, patent ductus arteriosus (PDA), necrotizing enterocolitis (NEC), packed red blood cell transfusions, intraventricular hemorrhage (IVH), periventricular leukomalacia, and survival to discharge. Results: ABO incongruent neonates between 27 and 32 weeks GA were more likely to have NEC and had a trend toward an increased incidence of early pulmonary hypertension. There were trends toward more heart dysfunction and severity of IVH in neonates between 22 and 26 weeks GA. Conclusion: ABO incongruency is associated with neonatal complications in the preterm population. This study is underpowered to adequately evaluate all neonatal morbidities. More studies are required to evaluate the effects of ABO incongruency on neonatal outcomes, particularly on NEC and pulmonary hypertension.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.